STRUCTURE OF 1-(3-METHYLPHENYL)-4-(2-BETA-QUINOLYLETHYL)PIPERAZINE - CENTHAQUIN

被引:10
|
作者
CARPY, A [1 ]
SAXENA, AK [1 ]
机构
[1] CENT DRUG RES INST,LUCKNOW 226001,UTTAR PRADESH,INDIA
关键词
D O I
10.1107/S0108270190007211
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
C22H25N3, centrally active hypotensive agent, antihypertensive, M(r) = 331.46, monoclinic, P2(1)/c, a = 9.122 (2), b = 22.108 (3), c = 9.165 (2) angstrom, beta = 102.20 (1)degrees, V = 1806.6 angstrom 3, Z = 4, D(x) = 1.22 g cm-3, lambda(Cu K-alpha) = 1.54178 angstrom, mu = 5.67 cm-1, F(000) = 712, room temperature, R = 0.043 for 1360 observed reflections. The methylphenyl substituted nitrogen exhibits sp2 character. The resonance of its axial lone pair with the phenyl ring is evidenced by the shortening of the bridge bond and by the almost parallel position of the phenyl ring and of the mean plane of the piperazine ring.
引用
收藏
页码:227 / 229
页数:3
相关论文
共 50 条
  • [1] PHARMACOLOGICAL STUDIES ON 2-(2-(4-(3-METHYLPHENYL)-1-PIPERAZINYL)ETHYL) QUINOLINE (CENTHAQUIN) .1. HYPOTENSIVE ACTIVITY
    SRIMAL, RC
    GULATI, K
    NITYANAND, S
    DHAWAN, BN
    PHARMACOLOGICAL RESEARCH, 1990, 22 (03) : 319 - 329
  • [2] STRUCTURE OF 1-[(4-ACETAMIDOPHENYL)THIO]-3-[4-(3-METHYLPHENYL)PIPERAZIN-L-YL]PROPANE MONOHYDRATE
    CARPY, A
    LEGER, JM
    RAO, J
    SAXENA, AK
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1991, 47 : 2704 - 2706
  • [3] STUDIES ON 2-(2-(4-(3-METHYLPHENYL)1-PIPERAZINYL)ETHYL QUINOLINE (CENTHAQUIN), A CENTRALLY ACTING ANTIHYPERTENSIVE .2. EFFECT ON CARDIOHEMODYNAMICS
    SRIMAL, RC
    MASON, DFJ
    DHAWAN, BN
    ASIA PACIFIC JOURNAL OF PHARMACOLOGY, 1990, 5 (03): : 185 - 190
  • [4] 4-[Amino(3-methylphenyl)methylidene]-2-(3-methylphenyl)-1H-imidazol-5(4H)-one ethanol hemisolvate
    Prabhuswamy, M.
    Kumar, S. Madan
    Muneer, C. P.
    Shafi, P. M.
    Lokanath, N. K.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O174 - +
  • [5] An unknown solvate of 1-(2,4-dichlorobenzyl)-4-[(4-methylphenyl)sulfonyl]piperazine
    Sreenivasa, S.
    ManojKumar, K. E.
    Anitha, H. C.
    Suchetan, P. A.
    Palakshamurthy, B. S.
    Jayashree, Yenagi
    Tonannavar, J.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O782 - +
  • [6] 1-(3-Methylphenyl)-3-{5-[4-(trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-yl}-urea
    Tan, Zhi-Wei
    Tan, Xiao-Hong
    Song, Xin-Jian
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2007, 63 : O3641 - U4746
  • [7] N-{4-[(3-Methylphenyl)sulfamoyl]phenyl}benzamide
    Lahtinen, Manu
    Damodara, Jyothi
    Upadhyaya, Poornima
    Nonappa
    Kolehmainen, Erkki
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2866 - +
  • [8] N-{4-[(3-Methylphenyl)sulfamoyl]phenyl}acetamide
    Farrukh, Muhammad Akhyar
    Qureshi, Fahim Ashraf
    Adnan, Ahmad
    Turktekin, Sevim
    Akkurt, Mehmet
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2012, 68 : O437 - U944
  • [9] 1-[1-(3-Methylphenyl)-5-phenyl-4-phenylsulfonyl-1H-pyrazol-3-yl]ethanone
    Ghazzali, Mohamed
    Abdel-Aziz, Hatem A.
    Al-Farhan, Khalid
    Ng, Seik Weng
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2922 - U375
  • [10] SYNTHESIS OF DERIVATIVES OF 1-(2- AND 3-METHYLPHENYL)-3--HYDROXYPYRIDAZIN-6-ONE
    BALONIAK, S
    MELZER, E
    ACTA POLONIAE PHARMACEUTICA, 1982, 39 (1-3): : 71 - 78